Company: ANTX
Filing Date: 2025-05-13
Form Type: 8-K
Source: 0000950170-25-070305
Chunk: 1

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-05-13
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

  Exhibit      Description                                                                  
                                                                                            
   Number                                                                                   
     99.1      Press Release of AN2 Therapeutics Inc. dated May 13, 2025                    
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                        AN2 Therapeutics, Inc.                
  Date:      May 13, 2025      By:      /s/ Eric Easom                        
                                        Eric Easom